Wearable & Sensor Videos

  1. The Digital Frontier Of Parkinson's Research: Advancing New Age Discovery 4/12/2022

    Beyond enabling data collection outside the clinic, new models are enhancing stakeholders' abilities to access more sensitive, frequent, and objective measures of Parkinson’s progression. 

  2. Why Site Burden Goes Beyond eSource 6/12/2026

    Beth Harper explains why the real problem is broader than eSource and why sponsors should integrate around the systems sites already use.

  3. Collaborative Effort To Advance Clinical Research With DHTs 6/13/2024

    Discover insights from the ActiGraph Digital Data Summit (ADDS), a unique gathering uniting researchers across academia and industry to promote digital health technology in clinical research, shaping the future of healthcare.

  4. Exploring The Role Of Wearable Biosensors Within The DCT Ecosystem 3/28/2022

    In this pre-recorded webinar, experts from the industry share real-world insights and practical guidance on how to achieve success in decentralized clinical trials.

  5. Maximize Your DHT Investment With ActiGraph Scientific Services 2/16/2024

    Discover how the ActiGraph Science Team collaborates closely with study teams to capture meaningful clinical outcomes remotely and continuously using sensor-based Digital Health Technologies.

  6. Advancing ALS Research With DHTs: Where Are We Now? 4/9/2024

    Rakesh Pilkar, Ph.D., and Marcin Straczkiewicz, Ph.D., unveil their latest endeavors in devising innovative metrics to quantify gait and upper limb movement for monitoring ALS progression.

  7. Wearables 101: Foundations, Regulations, And Real-World Applications 7/16/2024

    Chief Scientific Officer Christine Guo, Ph.D., provides key insights into DHTs aimed at empowering study teams to strategically integrate these technologies into their clinical development initiatives.

  8. Accelerate Parkinson's Drug Development With Active, Passive DHT Monitoring 4/15/2025

    Discover how a new ActiGraph–Indivi partnership is enhancing neurology clinical trials with digital health technologies that enable more sensitive, real-world outcome measures.

  9. Monitoring Activity And Gait In Children Using DHTs 6/13/2024

    Drug developers, researchers, patients, and regulators are recognizing the benefits of sensor-based digital health technologies for clinical research.

  10. Redefining ALS Clinical Endpoints: Unlocking The Potential Of DHT 10/20/2025

    ALS drug development struggles with trial failures due to complex biology and endpoints. Digital health offers sensitive, objective measures to improve clinical trial outcomes collaboratively.